Smithfield Trust Co Sells 912 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Smithfield Trust Co decreased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 6,318 shares of the company’s stock after selling 912 shares during the period. Smithfield Trust Co’s holdings in GE HealthCare Technologies were worth $493,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. J.Safra Asset Management Corp increased its stake in shares of GE HealthCare Technologies by 224.1% in the 4th quarter. J.Safra Asset Management Corp now owns 1,656 shares of the company’s stock valued at $130,000 after acquiring an additional 1,145 shares during the last quarter. Victory Capital Management Inc. grew its holdings in GE HealthCare Technologies by 0.8% during the fourth quarter. Victory Capital Management Inc. now owns 667,057 shares of the company’s stock valued at $52,151,000 after purchasing an additional 5,518 shares during the period. Keybank National Association OH increased its stake in GE HealthCare Technologies by 1.6% in the fourth quarter. Keybank National Association OH now owns 954,906 shares of the company’s stock valued at $74,655,000 after purchasing an additional 14,598 shares in the last quarter. Commerzbank Aktiengesellschaft FI raised its holdings in GE HealthCare Technologies by 29.6% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 3,788 shares of the company’s stock worth $296,000 after purchasing an additional 865 shares during the period. Finally, Patten Group Inc. boosted its position in shares of GE HealthCare Technologies by 34.1% during the fourth quarter. Patten Group Inc. now owns 10,084 shares of the company’s stock worth $788,000 after purchasing an additional 2,563 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the topic of several research analyst reports. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Stock Up 0.5 %

GE HealthCare Technologies stock opened at $84.76 on Thursday. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The company has a fifty day simple moving average of $86.52 and a 200 day simple moving average of $86.13. The company has a market cap of $38.76 billion, a P/E ratio of 19.58, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.